IMARC Group’s latest report, titled “Chemoinformatics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” finds that the global chemoinformatics market size reached US$ 5.7 Billion in 2022. Chemoinformatics refers to a field of information technology that relies on informational and computational techniques to provide a deeper understanding and solve chemistry problems. It involves the collection, storage, analysis, and manipulation of chemical data, including small molecule formulas, properties, structures, spectra, and biological and industrial activities. It helps represent three-dimensional (3D) molecular structures to enable the searching and comparing compounds with specific features while defining archival data protocols. As a result, chemoinformatics finds extensive applications in the pharmaceutical industry and the areas of biology, chemistry, and biochemistry.
Global Chemoinformatics Market Trends:
The increasing use of chemoinformatics in the drug discovery and development process to introduce novel biotechnological processes and products. Consequently, the rising preferences for personalized medicine and the widespread prevalence of chronic diseases represent the primary factors driving the market growth. Moreover, the recent coronavirus disease (COVID-19) outbreak has accelerated product adoption in anti-viral research and the discovery of therapeutics to curb the spread of the virus. Additionally, the growing need for efficient management of data generated during molecular and atomic reactions and validating potential drug candidates developed by combinatorial chemical methods has augmented the product demand. In line with this, extensive investments in research and development (R&D) projects have catalyzed market growth. Furthermore, the leading players are integrating advanced information storage and retrieval technologies in chemoinformatics to help researchers efficiently store data about physical properties, 3D molecular and crystal structures, chemical reaction pathways, and molecular functional groups and docking sites. Along with this, ongoing innovations and advancements in the drug development process are positively influencing market growth. Other factors, including the surging need for novel drugs, growing funding in biotechnology sectors to accelerate drug discovery, increasing use of in-silico techniques, and technological advancements, are also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 9.7 Billion by 2028, expanding at a CAGR of 11.1% during 2023-2028.
- Based on the application, the market has been classified into chemical analysis, drug discovery, drug validation, and others.
- Region-wise, the market has been divided into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has also been analyzed, with some of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSolveIT GmbH, BIOVIA (Dassault Systèmes), ChemAxon, Inc., Eurofins CEREP SA (Eurofins Panlabs Inc.), Jubilant Biosys Inc., Molecular Discovery Ltd., OpenEye Scientific Software Inc., and Schrödinger Inc.
|Base Year of the Analysis
||Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioSolveIT GmbH, BIOVIA (Dassault Systèmes), ChemAxon, Inc., Eurofins CEREP SA (Eurofins Panlabs Inc.), Jubilant Biosys Inc., Molecular Discovery Ltd., OpenEye Scientific Software Inc. and Schrödinger Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800